0001209191-22-017346.txt : 20220308
0001209191-22-017346.hdr.sgml : 20220308
20220308200213
ACCESSION NUMBER: 0001209191-22-017346
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220304
FILED AS OF DATE: 20220308
DATE AS OF CHANGE: 20220308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Ryan Edward
CENTRAL INDEX KEY: 0001848718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 22723503
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: STE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-04
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001848718
Brown Ryan Edward
215 FIRST STREET
CAMBRIDGE
MA
02124
0
1
0
0
SVP, General Counsel
Common Stock
2022-03-04
4
F
0
1136
79.20
D
18048
D
Common Stock
2022-03-07
4
F
0
153
79.36
D
17895
D
Common Stock
2022-03-07
4
A
0
8000
0.00
A
25895
D
Stock Option (right to buy)
80.42
2022-03-07
4
A
0
48000
0.00
A
2023-03-07
2032-03-07
Common Stock
48000
48000
D
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 4, 2019.
The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.
/s/ Ryan E. Brown
2022-03-08